Advertisement
UK markets close in 7 hours 44 minutes

  • FTSE 100

    8,061.33
    +37.46 (+0.47%)
     

  • FTSE 250

    19,657.78
    +58.39 (+0.30%)
     

  • AIM

    751.02
    +1.84 (+0.25%)
     

  • GBP/EUR

    1.1574
    -0.0015 (-0.13%)
     

  • GBP/USD

    1.2363
    +0.0013 (+0.10%)
     

  • Bitcoin GBP

    53,533.23
    +100.45 (+0.19%)
     

  • CMC Crypto 200

    1,396.69
    -18.06 (-1.28%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    82.41
    +0.51 (+0.62%)
     

  • GOLD FUTURES

    2,323.90
    -22.50 (-0.96%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,824.80
    +313.11 (+1.90%)
     

  • DAX

    17,984.45
    +123.65 (+0.69%)
     

  • CAC 40

    8,057.83
    +17.47 (+0.22%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

BUZZ-Healthcare M&A: what the doctor ordered

Reuters - UK Focus

A spate of deal headlines in the European pharma sector is putting a floor under regional stock indices.

** Busy Easter for dealmakers with Novartis (Xetra: NOT.DE - news) and GlaxoSmithKline (Other OTC: GLAXF - news) leading the charge.

** Pfizer (NYSE: PFE - news) could get back into mega-deal mode after a 4-year hiatus. A reported 60 billion pound offer for AstraZeneca (EUREX: AZNF.EX - news) was rejected.

** Citi expects renewed interest in the use of offshore cash held by US companies to fund ex-US M&A.

** Among potential candidates for takeovers Citi points to previously cited targets including Shire (LSE: SHP.L - news) , Actelion & UCB.

** A pick-up in corporate activity especially in the form of deals at hefty premiums to current prices could tempt investors to chase stocks. (RM (LSE: RM.L - news) : vikram.subhedar.thomsonreuters.com@reuters.net)